Valuation: NORW ACQUPAR

Market Cap 13.37M 12M 11.09M 10.04M 18.77M 1.27B 18.99M 133M 52.82M 666M 50.18M 49.12M 2.12B P/E 2023
96.6x
P/E 2024 -6.98x
Enterprise Value 23.05M 20.68M 19.12M 17.32M 32.36M 2.2B 32.75M 229M 91.07M 1.15B 86.51M 84.69M 3.65B EV / Sales 2023
-
EV / Sales 2024 -
Free-Float
-
Yield 2023 *
-
Yield 2024 -
1 day-1.78%
Current month-69.38%
Current year-69.38%
3 years 0.7
Extreme 0.7
13
5 years 0.7
Extreme 0.7
13
10 years 0.7
Extreme 0.7
13

Financials

2023 2024
Net sales - -
Net income 1.16M 1.04M 964K 873K 1.63M 111M 1.65M 11.52M 4.59M 57.91M 4.36M 4.27M 184M -8.71M -7.82M -7.23M -6.54M -12.23M -830M -12.37M -86.4M -34.41M -434M -32.69M -32M -1.38B
Net Debt 940K 843K 779K 706K 1.32M 89.49M 1.33M 9.32M 3.71M 46.83M 3.53M 3.45M 149M 9.68M 8.69M 8.03M 7.27M 13.59M 922M 13.76M 96.04M 38.25M 483M 36.34M 35.57M 1.53B
Projected Income Statement - Annual - NORW ACQUPAR
Logo NORW ACQUPAR
NorthView Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The Company intends to focus its search on businesses that are focused on the biopharmaceutical, medical technology/medical device, and diagnostics space, which aligns with the management team’s experience in operating health care companies and in drug and device technology development as well as diagnostic and other services. The Company is not engaged in any business operations and has not generated any revenue.
Employees
-
Sector
-
Date Price Change
29/10/26 $0.7656 -1.78%
27/10/26 $0.7795 -0.03%
26/10/26 $0.7797 -7.08%
23/10/26 $0.8391 -17.74%
22/10/26 $1.020 +20.11%
  1. Stock Market
  2. Stocks
  3. NVAC Stock